A rationale for systemic treatment in onychomycosis with negative results on fungal examination

Clinical and Experimental Dermatology

Volumn 36, Issue 7, 2011, Pages 724-727

  Amichai, B ^a   Davidovici, B ^b   Trau, H ^a   Lyakhovitsky, A ^a   Grunwald, M H ^c   Shemer, A ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM HYDROXIDE;

ADULT; AGED; ARTICLE; CLINICAL DECISION MAKING; DERMATOPHYTE; FEMALE; FUNGUS CULTURE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC THERAPY; TOENAIL ONYCHOMYCOSIS; TRICHOPHYTON RUBRUM;

ADULT; AGED; ANTIFUNGAL AGENTS; FEMALE; FOOT DERMATOSES; HUMANS; MALE; MIDDLE AGED; ONYCHOMYCOSIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRICHOPHYTON; YOUNG ADULT;

EID: 80052969903     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04082.x     Document Type: Article

References (16)

1. Scher RK,. Onychomycosis: therapeutic update. J Am Acad Dermatol 1999; 40 (Suppl.): S21-6. (Pubitemid 29264669)
2. Elewski BE, Charif MA,. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch Dermatol 1997; 133: 1172-3. (Pubitemid 27408228)
3. Achten G, Wanet-Rouard J,. Onychomycosis in laboratory. Mykosen 1978; 23: 125-7.
4. Weinberg JM, Koestenblatt EK, Tutrone WD, et al. Comparison of diagnostic methods in the evaluation of onychomycosis. J Am Acad Dermatol 2003; 49: 193-7. (Pubitemid 36951263)
5. Arnold B, Kianifrad F, Tavakkol A,. A compression of KOH and culture results from two mycology laboratories for the diagnosis of onychomycosis during a randomized, multicenter clinical trial: a subset study. J Am Podiatr Med Assoc 2005; 95: 421-3.
6. Elewski BE,. Diagnostic techniques for confirming onychomycosis. J Am Acad Dermatol 1996; 35: S6-9.
7. Leyden J,. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol 1998; 38: S42-7. (Pubitemid 28215622)
8. de Chauvin MF,. New diagnostic techniques. J Eur Acad Dermatol Venereol 2005; 19 (Suppl. 1): 20-4. (Pubitemid 41726926)
9. Shemer A, Trau H, Davidovici B, et al. Nail sampling in onychomycosis: comparative study of curettage from three sites of the infected nail. J Dtsch Dermatol Ges 2007; 5: 1108-11. (Pubitemid 350239468)
10. Shemer A, Trau H, Davidovici B, et al. Collection of fungi samples from nails-comparative study of curettage and drilling techniques. J Eur Acad Dermatol Venereol 2008; 22: 182-5.
11. Gupta AK, Zaman M, Singh J,. Fast and sensitive detection of Trichophyton rubrum DNA from the nail samples of patients with onychomycosis by a double-round polymerase chain reaction-based assay. Br J Dermatol 2007; 157: 698-703. (Pubitemid 47389894)
12. Garg J, Tilak R, Singh S, et al. Evaluation of pan-dermatophyte nested PCR in diagnosis of onychomycosis. J Clin Microbiol 2007; 45: 3443-5. (Pubitemid 47585684)
13. Daniel CR 3rd, Elewski BE,. The diagnosis of nail fungus infection revisited. Arch Dermatol 2000; 136: 1162-4.
14. Finch JJ, Warshaw EM,. Toenail onychomycosis: current and future treatment options. Dermatol Ther 2007; 20: 31-46. (Pubitemid 46568375)
15. Cribier BJ, Bakshi R,. Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections. Br J Dermatol 2004; 150: 414-20. (Pubitemid 38446294)
16. Elewski B, Tavakkol A,. Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality. Ther Clin Risk Manag 2005; 1: 299-306.